Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MARC GRASSO Insider Profile
4 Followers
MARC GRASSO, CFO, CBO at Kura Oncology, holds 130.74K shares in Alector (Ticker: ALEC), holds 21.90K shares in Kura Oncology (Ticker: KURA). Most recently, MARC GRASSO Sold ― shares of Alector on Sep 04, 2024 for an estimated value of 35.61K.
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+2.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by MARC GRASSO
MARC GRASSO's Trading History
Kura Oncology
Jan 28, 2022
CFO, CBO
Uninformative Buy
―
$384.56K
Alector
Sep 04, 2024
CFO
Informative Sell
35.61K
$792.28K
List of latest transactions for each holding click on a transaction to see MARC GRASSO's performance on stock
You May Also Like
MARC GRASSO insider profile FAQ
What is the percentage of profitable transactions made by MARC GRASSO?
The percentage of profitable transactions made by MARC GRASSO is 57%.
What is the average return per transaction made by MARC GRASSO?
The average return per transaction made by MARC GRASSO is 2.10%.
What stocks does MARC GRASSO hold?
MARC GRASSO holds: KURA, ALEC stocks.
What was MARC GRASSO’s latest transaction?
MARC GRASSO latest transaction was an Informative Sell of $35.61K.
What was MARC GRASSO's most profitable transaction?
MARC GRASSO’s most profitable transaction was an Informative Sell of ALEC stock on June 5, 2023. The return on the trade was 33.20%.
What is MARC GRASSO's role in Kura Oncology?
MARC GRASSO's role in Kura Oncology is CFO, CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.